301 related articles for article (PubMed ID: 32330228)
1. In Vivo CRISPR/Cas9-Mediated Genome Editing Mitigates Photoreceptor Degeneration in a Mouse Model of X-Linked Retinitis Pigmentosa.
Hu S; Du J; Chen N; Jia R; Zhang J; Liu X; Yang L
Invest Ophthalmol Vis Sci; 2020 Apr; 61(4):31. PubMed ID: 32330228
[TBL] [Abstract][Full Text] [Related]
2. In Situ Gene Therapy via AAV-CRISPR-Cas9-Mediated Targeted Gene Regulation.
Moreno AM; Fu X; Zhu J; Katrekar D; Shih YV; Marlett J; Cabotaje J; Tat J; Naughton J; Lisowski L; Varghese S; Zhang K; Mali P
Mol Ther; 2018 Jul; 26(7):1818-1827. PubMed ID: 29754775
[TBL] [Abstract][Full Text] [Related]
3. Restoration of RPGR expression in vivo using CRISPR/Cas9 gene editing.
Gumerson JD; Alsufyani A; Yu W; Lei J; Sun X; Dong L; Wu Z; Li T
Gene Ther; 2022 Feb; 29(1-2):81-93. PubMed ID: 34257417
[TBL] [Abstract][Full Text] [Related]
4. In Vivo CRISPR/Cas9 Gene Editing Corrects Retinal Dystrophy in the S334ter-3 Rat Model of Autosomal Dominant Retinitis Pigmentosa.
Bakondi B; Lv W; Lu B; Jones MK; Tsai Y; Kim KJ; Levy R; Akhtar AA; Breunig JJ; Svendsen CN; Wang S
Mol Ther; 2016 Mar; 24(3):556-63. PubMed ID: 26666451
[TBL] [Abstract][Full Text] [Related]
5. Toxicity and Efficacy Evaluation of an Adeno-Associated Virus Vector Expressing Codon-Optimized
Dufour VL; Cideciyan AV; Ye GJ; Song C; Timmers A; Habecker PL; Pan W; Weinstein NM; Swider M; Durham AC; Ying GS; Robinson PM; Jacobson SG; Knop DR; Chulay JD; Shearman MS; Aguirre GD; Beltran WA
Hum Gene Ther; 2020 Feb; 31(3-4):253-267. PubMed ID: 31910043
[TBL] [Abstract][Full Text] [Related]
6. CRISPR-Based Genome Editing as a New Therapeutic Tool in Retinal Diseases.
Rasoulinejad SA; Maroufi F
Mol Biotechnol; 2021 Sep; 63(9):768-779. PubMed ID: 34057656
[TBL] [Abstract][Full Text] [Related]
7. AAV-Mediated CRISPR/Cas Gene Editing of Retinal Cells In Vivo.
Hung SS; Chrysostomou V; Li F; Lim JK; Wang JH; Powell JE; Tu L; Daniszewski M; Lo C; Wong RC; Crowston JG; Pébay A; King AE; Bui BV; Liu GS; Hewitt AW
Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3470-6. PubMed ID: 27367513
[TBL] [Abstract][Full Text] [Related]
8. AAV-RPGR Gene Therapy Rescues Opsin Mislocalisation in a Human Retinal Organoid Model of
Sladen PE; Naeem A; Adefila-Ideozu T; Vermeule T; Busson SL; Michaelides M; Naylor S; Forbes A; Lane A; Georgiadis A
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339118
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/SaCas9-based gene editing rescues photoreceptor degeneration throughout a rhodopsin-associated autosomal dominant retinitis pigmentosa mouse model.
Du W; Li J; Tang X; Yu W; Zhao M
Exp Biol Med (Maywood); 2023 Oct; 248(20):1818-1828. PubMed ID: 37837380
[TBL] [Abstract][Full Text] [Related]
10. In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration.
Suzuki K; Tsunekawa Y; Hernandez-Benitez R; Wu J; Zhu J; Kim EJ; Hatanaka F; Yamamoto M; Araoka T; Li Z; Kurita M; Hishida T; Li M; Aizawa E; Guo S; Chen S; Goebl A; Soligalla RD; Qu J; Jiang T; Fu X; Jafari M; Esteban CR; Berggren WT; Lajara J; Nuñez-Delicado E; Guillen P; Campistol JM; Matsuzaki F; Liu GH; Magistretti P; Zhang K; Callaway EM; Zhang K; Belmonte JC
Nature; 2016 Dec; 540(7631):144-149. PubMed ID: 27851729
[TBL] [Abstract][Full Text] [Related]
11. Allele-specific editing ameliorates dominant retinitis pigmentosa in a transgenic mouse model.
Patrizi C; Llado M; Benati D; Iodice C; Marrocco E; Guarascio R; Surace EM; Cheetham ME; Auricchio A; Recchia A
Am J Hum Genet; 2021 Feb; 108(2):295-308. PubMed ID: 33508235
[TBL] [Abstract][Full Text] [Related]
12. Gene editing prospects for treating inherited retinal diseases.
Benati D; Patrizi C; Recchia A
J Med Genet; 2020 Jul; 57(7):437-444. PubMed ID: 31857428
[TBL] [Abstract][Full Text] [Related]
13. Allele-Specific Knockout by CRISPR/Cas to Treat Autosomal Dominant Retinitis Pigmentosa Caused by the G56R Mutation in NR2E3.
Diakatou M; Dubois G; Erkilic N; Sanjurjo-Soriano C; Meunier I; Kalatzis V
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807610
[TBL] [Abstract][Full Text] [Related]
14. Precision Medicine: Genetic Repair of Retinitis Pigmentosa in Patient-Derived Stem Cells.
Bassuk AG; Zheng A; Li Y; Tsang SH; Mahajan VB
Sci Rep; 2016 Jan; 6():19969. PubMed ID: 26814166
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic In Vivo Gene Editing Achieved by a Hypercompact CRISPR-Cas12f1 System Delivered with All-in-One Adeno-Associated Virus.
Cui T; Cai B; Tian Y; Liu X; Liang C; Gao Q; Li B; Ding Y; Li R; Zhou Q; Li W; Teng F
Adv Sci (Weinh); 2024 May; 11(19):e2308095. PubMed ID: 38408137
[TBL] [Abstract][Full Text] [Related]
16. CRISPR Repair Reveals Causative Mutation in a Preclinical Model of Retinitis Pigmentosa.
Wu WH; Tsai YT; Justus S; Lee TT; Zhang L; Lin CS; Bassuk AG; Mahajan VB; Tsang SH
Mol Ther; 2016 Aug; 24(8):1388-94. PubMed ID: 27203441
[TBL] [Abstract][Full Text] [Related]
17. Long-term rescue of cone photoreceptor degeneration in retinitis pigmentosa 2 (RP2)-knockout mice by gene replacement therapy.
Mookherjee S; Hiriyanna S; Kaneshiro K; Li L; Li Y; Li W; Qian H; Li T; Khanna H; Colosi P; Swaroop A; Wu Z
Hum Mol Genet; 2015 Nov; 24(22):6446-58. PubMed ID: 26358772
[TBL] [Abstract][Full Text] [Related]
18. Nrl knockdown by AAV-delivered CRISPR/Cas9 prevents retinal degeneration in mice.
Yu W; Mookherjee S; Chaitankar V; Hiriyanna S; Kim JW; Brooks M; Ataeijannati Y; Sun X; Dong L; Li T; Swaroop A; Wu Z
Nat Commun; 2017 Mar; 8():14716. PubMed ID: 28291770
[TBL] [Abstract][Full Text] [Related]
19. A long-term efficacy study of gene replacement therapy for RPGR-associated retinal degeneration.
Wu Z; Hiriyanna S; Qian H; Mookherjee S; Campos MM; Gao C; Fariss R; Sieving PA; Li T; Colosi P; Swaroop A
Hum Mol Genet; 2015 Jul; 24(14):3956-70. PubMed ID: 25877300
[TBL] [Abstract][Full Text] [Related]
20. Molecular Strategies for RPGR Gene Therapy.
Cehajic Kapetanovic J; McClements ME; Martinez-Fernandez de la Camara C; MacLaren RE
Genes (Basel); 2019 Sep; 10(9):. PubMed ID: 31487940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
